Metraipolis › archive › dc_560cdcc83470
Real-world Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in ≥50-year-old Adults With Autoimmune Diseases — Europe PMC PMID:40795879
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40795879
- DOI
- 10.1093/infdis/jiaf395
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T02:13:46.797Z
- SHA-256 of the archived text
402c05dad6d944bfbd9e468914002057bd7316716bc06b5b3a305ca08a1dfe62- Stable URL of this page
https://metraipolis.com/documento/dc_560cdcc83470
How to cite
Real-world Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in ≥50-year-old Adults With Autoimmune Diseases — Europe PMC PMID:40795879 — Europe PMC (en), https://europepmc.org/article/MED/40795879 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_560cdcc83470 (Metraipolis archive dc_560cdcc83470, sha256 402c05dad6d944bfbd9e468914002057bd7316716bc06b5b3a305ca08a1dfe62)
BibTeX
@misc{dc560cdcc83470,
title = {Real-world Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in ≥50-year-old Adults With Autoimmune Diseases — Europe PMC PMID:40795879},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40795879},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_560cdcc83470; sha256 402c05dad6d944bfbd9e468914002057bd7316716bc06b5b3a305ca08a1dfe62},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40795879. Agents can read the archived copy with the MCP tool read_document.